DK0553016T3 - Hidtil ukendte naphtalenamider og -sulfonamider, fremgangsmåder til deres fremstilling samt farmaceutiske midler indeholdende dem - Google Patents
Hidtil ukendte naphtalenamider og -sulfonamider, fremgangsmåder til deres fremstilling samt farmaceutiske midler indeholdende demInfo
- Publication number
- DK0553016T3 DK0553016T3 DK93400111.6T DK93400111T DK0553016T3 DK 0553016 T3 DK0553016 T3 DK 0553016T3 DK 93400111 T DK93400111 T DK 93400111T DK 0553016 T3 DK0553016 T3 DK 0553016T3
- Authority
- DK
- Denmark
- Prior art keywords
- naphthalenamides
- sulfonamides
- preparation
- new
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/31—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms
- C07C311/35—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9200608A FR2686339B1 (fr) | 1992-01-22 | 1992-01-22 | Nouveaux amides et sulfonamides naphtaleniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0553016T3 true DK0553016T3 (da) | 1997-12-01 |
Family
ID=9425835
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK93400111.6T DK0553016T3 (da) | 1992-01-22 | 1993-01-19 | Hidtil ukendte naphtalenamider og -sulfonamider, fremgangsmåder til deres fremstilling samt farmaceutiske midler indeholdende dem |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5332759A (de) |
| EP (1) | EP0553016B1 (de) |
| JP (1) | JPH0694448B2 (de) |
| AT (1) | ATE152707T1 (de) |
| AU (1) | AU654753B2 (de) |
| CA (1) | CA2087772A1 (de) |
| DE (1) | DE69310391T2 (de) |
| DK (1) | DK0553016T3 (de) |
| ES (1) | ES2103440T3 (de) |
| FR (1) | FR2686339B1 (de) |
| GR (1) | GR3023934T3 (de) |
| NZ (1) | NZ245728A (de) |
| ZA (1) | ZA93494B (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3717561A1 (de) * | 1987-05-25 | 1988-12-08 | Thomae Gmbh Dr K | Indol-, isochinolin- und benzazepinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| US6010622A (en) * | 1996-12-18 | 2000-01-04 | Dandy Enterprises Limited | Environmental filter |
| US5632888A (en) * | 1995-05-11 | 1997-05-27 | Dandy Enterprises Limited | Environmental filter |
| WO2003079986A2 (en) | 2002-03-18 | 2003-10-02 | Bristol-Myers Squibb Company | Uracil derivatives as inhibitors of tnf-alpha converting enzyme (tace) and matrix metalloproteinases |
| EP1534679A4 (de) * | 2002-08-30 | 2007-06-06 | Biostratum Inc | Inhibitoren von post-amadori advanced glycation endproducts |
| US7109337B2 (en) | 2002-12-20 | 2006-09-19 | Pfizer Inc | Pyrimidine derivatives for the treatment of abnormal cell growth |
| CA2529611C (en) | 2002-12-20 | 2009-12-15 | Pfizer Products Inc. | Pyrimidine derivatives for the treatment of abnormal cell growth |
| WO2005111024A1 (en) | 2004-05-14 | 2005-11-24 | Pfizer Products Inc. | Pyrimidine derivatives for the treatment of abnormal cell growth |
| MXPA06013165A (es) | 2004-05-14 | 2007-02-13 | Pfizer Prod Inc | Derivados de pirimidina para el tratamiento de crecimiento de celulas anormal. |
| EP1751142A1 (de) | 2004-05-14 | 2007-02-14 | Pfizer Products Incorporated | Pyrimidinderivate zur behandlung von anormalem zellwachstum |
| EP1848430B1 (de) | 2004-12-31 | 2017-08-02 | Dr. Reddy's Laboratories Ltd. | Neue benzylaminderivate als cetp-inhibitoren |
| US8604055B2 (en) | 2004-12-31 | 2013-12-10 | Dr. Reddy's Laboratories Ltd. | Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors |
| EP2744803A2 (de) | 2011-08-18 | 2014-06-25 | Dr. Reddy's Laboratories Ltd. | Substituierte heterocyclische aminverbindungen als cholestryl-ester-transfer-protein (cetp)-inhibitoren |
| EP2760864B1 (de) | 2011-09-27 | 2018-01-24 | Dr. Reddy's Laboratories Ltd. | 5-BENZYLAMINOMETHYL-6-AMINOPYRAZOLO[3,4-b]PYRIDIN-DERIVATE ALS CHOLESTERYL-ESTER-TRANSFER-PROTEIN (CETP) INHIBITOREN VERWENDBAR FÜR DIE BEHANDLUNG VON ATHEROSKLEROSE |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4217306A (en) * | 1978-05-01 | 1980-08-12 | G. D. Searle & Co. | α-Aryl-α,α-bis[ω-(disubstituted amino)alkyl]-acetamides |
| GB2082175B (en) * | 1980-08-12 | 1984-05-02 | Glaxo Group Ltd | Heterocyclic compounds |
| EP0091749A3 (de) * | 1982-04-08 | 1984-12-05 | Beecham Group Plc | Ethanolamin-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen |
| GB2162522B (en) * | 1984-08-01 | 1988-02-24 | Glaxo Group Ltd | An indole derivative |
| DE3719924A1 (de) * | 1986-12-22 | 1988-06-30 | Bayer Ag | 8-substituierte 2-aminotetraline |
| US4900739A (en) * | 1988-10-20 | 1990-02-13 | American Home Products Corp. | Novel spirosuccinimides as aldose reductase inhibitors and antihyperglycemic agents |
| DE3932403A1 (de) * | 1989-05-12 | 1991-04-11 | Thomae Gmbh Dr K | Neue arylsulfonamide, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| HUT57185A (en) * | 1990-03-21 | 1991-11-28 | Merrell Dow Pharma | Process for producing 8-sulfamil-methylen-2-amino-tetraline derivatives and pharmaceutical compositions containing them |
| DE59108699D1 (de) * | 1990-08-10 | 1997-06-12 | Ciba Geigy Ag | Naphthylalkylaminopyrimidin-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Schädlingsbekämpfungsmittel |
-
1992
- 1992-01-22 FR FR9200608A patent/FR2686339B1/fr not_active Expired - Fee Related
-
1993
- 1993-01-19 EP EP93400111A patent/EP0553016B1/de not_active Expired - Lifetime
- 1993-01-19 AT AT93400111T patent/ATE152707T1/de not_active IP Right Cessation
- 1993-01-19 DE DE69310391T patent/DE69310391T2/de not_active Expired - Fee Related
- 1993-01-19 ES ES93400111T patent/ES2103440T3/es not_active Expired - Lifetime
- 1993-01-19 DK DK93400111.6T patent/DK0553016T3/da active
- 1993-01-21 CA CA002087772A patent/CA2087772A1/fr not_active Abandoned
- 1993-01-21 AU AU31912/93A patent/AU654753B2/en not_active Ceased
- 1993-01-21 NZ NZ245728A patent/NZ245728A/en unknown
- 1993-01-21 US US08/009,922 patent/US5332759A/en not_active Expired - Fee Related
- 1993-01-22 JP JP5043149A patent/JPH0694448B2/ja not_active Expired - Lifetime
- 1993-01-22 ZA ZA93494A patent/ZA93494B/xx unknown
-
1997
- 1997-06-30 GR GR970401582T patent/GR3023934T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0625128A (ja) | 1994-02-01 |
| FR2686339A1 (fr) | 1993-07-23 |
| FR2686339B1 (fr) | 1994-03-11 |
| ATE152707T1 (de) | 1997-05-15 |
| ES2103440T3 (es) | 1997-09-16 |
| US5332759A (en) | 1994-07-26 |
| AU654753B2 (en) | 1994-11-17 |
| DE69310391T2 (de) | 1997-12-18 |
| EP0553016A1 (de) | 1993-07-28 |
| DE69310391D1 (de) | 1997-06-12 |
| NZ245728A (en) | 1995-04-27 |
| AU3191293A (en) | 1993-07-29 |
| CA2087772A1 (fr) | 1993-07-23 |
| GR3023934T3 (en) | 1997-09-30 |
| EP0553016B1 (de) | 1997-05-07 |
| JPH0694448B2 (ja) | 1994-11-24 |
| ZA93494B (en) | 1993-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0562956T3 (da) | Hidtil ukendte naphthylalkylaminer, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
| DK0530087T3 (da) | Hidtil ukendte naphthylethylurinstof- og naphthylethylthiourinstofforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
| HUP0101999A2 (hu) | 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása | |
| ES2191048T3 (es) | Derivados de oxazolidinona y compuestos farmaceuticos que los contienen. | |
| DK0580502T3 (da) | 3-(hydroxybenzylidenyl)-indolin-2-oner og farmaceutiske sammensætninger indeholdende disse | |
| DK0404283T3 (da) | 11alfa-aryl-4-estrener, fremgangsmåde til fremstilling af disse samt deres anvendelse som lægemidler | |
| DK0553016T3 (da) | Hidtil ukendte naphtalenamider og -sulfonamider, fremgangsmåder til deres fremstilling samt farmaceutiske midler indeholdende dem | |
| DK0587499T3 (da) | Benzopyranforbindelser, fremgangsmåde til deres fremstilling og deres anvendelse som cellebeskyttelsesmidler | |
| DK0632026T3 (da) | Alfa-aminosyrederivater, en fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger, der indeholder dem | |
| DK0452204T3 (da) | Hidtil ukendte 3-aminochromanderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
| DK0533516T3 (da) | Hidtil ukendte 1-(alkoxybenzyl)piperazinamidforbindelser, fremgangsmåder til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
| ES2123728T3 (es) | Derivados de pirrolo-pirazina de actividad 5-ht3. | |
| DK0580503T3 (da) | Aminoalkylchromoner, fremgangsmåde til fremstilling heraf samt midler indeholdende disse | |
| DK11089D0 (da) | 2,5-diazabicyclooe2.2.1aaheptan-forbindelser, deres anvendelse til fremstilling af antiarytmi-laegemidler, farmaceutiske praeparater indeholdende forbindelserne samt forbindelse til anvendelse som udgangsmateriale ved deres fremstilling | |
| DK0574312T3 (da) | Diacylglycerolnicotinater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
| DK0612763T3 (da) | Cykliske angiopeptinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
| ES2062214T3 (es) | Derivados de aminooligohidroxi inhibidores de renina. | |
| DK0578535T3 (da) | Hidtil ukendt peptid-derivater, der er aktive i celleadhæsionsprocesser, fremgangsmåde til deres fremstilling samt farmaceutiske sammensætninger indeholdende derivarerne | |
| DK0611755T3 (da) | Hidtil ukendte (cyklohexyl)alkenforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
| DK0587048T3 (da) | Heteroarenylpiperaziner, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler | |
| ES2103553T3 (es) | Nuevos cicloalquil-(b)-indoles, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
| ZA933942B (en) | Pyrrolothienopyrazine compounds, processes for the preparation thereof and pharmaceutical compositions containing them | |
| NO976101D0 (no) | Nye ellipticinforbindelser, en fremgangsmåte ved deres fremstilling, samt farmasöytiske blandinger som inneholder dem |